TOWA CORPORATION
6315・Prime Market・Machinery
Business
TOWA Corporation, founded in 1979, is a manufacturer of semiconductor manufacturing equipment and precision molds headquartered in Kyoto. Its core Semiconductor Manufacturing Equipment Business supplies Molding Equipment (Transfer/Compression), Singulation Equipment, and precision molds to semiconductor manufacturers worldwide, accounting for approximately 92% of net sales. The Medical Device Business handles Plastic Molded Products for Medical Devices and Assembled Products for Medical Devices, while the Laser Processing Equipment Business develops laser processing equipment through TOWA Laser Front Corporation. The group consists of 22 companies including the Company, with sales and manufacturing bases located worldwide, including Taiwan, China, South Korea, Malaysia, Europe, and the Americas. Major customers are semiconductor manufacturing companies, centered on major memory manufacturers and advanced logic semiconductor manufacturers.
Business Model
All products are manufactured on a build-to-order basis, with revenue generated in line with customers' capital expenditure plans. After the initial delivery of equipment, ongoing demand arises for TSS (Total Solution Service, after-sales service) as utilization rates improve, as well as for precision molds as consumables, complementing recurring revenue. Through technological innovation backed by R&D expenditure of ¥816 million, the company continues to introduce high-value-added products, aiming to improve profit margins through an improved product mix.
Company Strengths
In the recovery phase of capital expenditure for general-purpose DRAM and HBM, the company has steadily captured demand for Molding Equipment, which has a strong adoption track record in the memory field, achieving a record-high net sales of ¥54,365 million in FY2026 (ending March 2026). Long-standing customer relationships and product track record form a barrier to entry for new orders.
The company has built a 22-company global structure spanning Taiwan, China, South Korea, Malaysia, Singapore, Europe/the U.S., and India (established April 2025). In FY2026 (ending March 2026), sales to Taiwan and China increased, with orders received rising 124.2% year on year to ¥54,067 million. A locally rooted sales and service structure serves as a differentiating factor versus competitors.
As of the end of FY2026 (ending March 2026), the equity ratio stood at 66.4%, with cash and cash equivalents of ¥26,381 million. The company has entered into overdraft and commitment line agreements totaling ¥18,500 million with six partner banks, securing an unused facility of ¥7,000 million. This financial soundness supports the continuation of proactive capital expenditure and R&D investment.
ENVALITH's Perspective
Performance Trend
Revenue bottomed out at ¥50,472 million in FY2024 (ending March 2024) and increased for two consecutive periods, reaching a record high of ¥54,365 million in FY2026 (ending March 2026). However, operating profit has continued on a downward trend since peaking at ¥11,505 million in FY2022 (ending March 2022), falling to ¥6,917 million (operating margin of 12.7%) in FY2026 (ending March 2026), the lowest level in five periods. As an external factor, the impact of U.S. tariff policy at the start of the period led to a sluggish beginning, but a recovery in investment for general-purpose DRAM from the second half drove revenue growth. On the other hand, upfront cost burdens associated with the first unit of the Compression Equipment and a decline in the proportion of high-margin products weighed on profit. Net income fell sharply to ¥4,593 million (down 43.4% year on year). For FY2027 (ending March 2027), the company forecasts a substantial recovery, with revenue of ¥64,000 million and operating profit of ¥10,240 million.
Growth Strategy
Based on TOWA Vision 2032, the company aims to capture AI and memory investment demand and achieve net sales of ¥71,000 million in FY2028 (ending March 2028)
Promoting expanded adoption of proprietary Compression Equipment for AI-related memory and next-generation logic semiconductors utilizing PLP. As the upfront cost burden of the initial unit projects passes its peak, product mix improvement and margin recovery are expected from FY2027 (ending March 2027) onward.
During the current fiscal year, the company newly established TOWA SEMICONDUCTOR INDIA PRIVATE LIMITED, TOWA MALAYSIA SALES & SERVICES SDN. BHD., and Wachuang Semiconductor Equipment (Shenzhen) Co., Ltd., expanding to a consolidated group of 21 subsidiaries. Continuing to acquire property, plant and equipment (¥3,274 million in the current fiscal year) to maintain and expand production capacity.
Against a backdrop of steady demand for Plastic Molded Products for Medical Devices and Assembled Products for Medical Devices, the company continues to invest in personnel costs and other areas to expand the business scale. Net sales for FY2026 (ending March 2026) trended firmly at ¥2,487 million (up 9.9% year on year), and the company aims to enhance added value by strengthening its integrated production system.
Due to sluggish capital expenditure demand for the mainstay Laser Trimmer Equipment, the business fell into an operating loss of ¥53 million in FY2026 (ending March 2026). The company aims to achieve the medium-term management plan's net sales target of ¥2,800 million through strengthening cost competitiveness via in-house production of oscillation units, transitioning to a subscription business model, and entering the semiconductor process field as a new market.
Last updated: July 19, 2026